Related Experiment Video
Updated: Nov 7, 2025

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
PROVE-Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
Lina Bergman1,2,3, Karl Bergman4, Eduard Langenegger3
1Department of Women's and Children's Health, Uppsala University, 75309 Uppsala, Sweden.
Insights
This study establishes a pre-eclampsia biobank in South Africa to research severe disease. It collects samples and data to understand pathophysiology and predict complications.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Research
- Neurology
Background:
- Pre-eclampsia is a major global cause of maternal and infant mortality, particularly in low-middle income countries.
- Severe pre-eclampsia can lead to significant organ damage, impacting long-term health.
- There is a critical need for research infrastructure to study this condition in high-incidence regions.
Purpose of the Study:
- To establish a pre-eclampsia biobank in South Africa for comprehensive research.
- To focus on phenotyping severe pre-eclampsia and its organ complications.
- To facilitate research into pathophysiology, prediction, and potential therapeutic targets.
Main Methods:
- Collection of biological specimens and detailed clinical data from women with pre-eclampsia and controls.
- Inclusion of advanced biophysical examinations: brain MRI, cardiac MRI, transcranial Doppler, echocardiography, and cognitive tests.
- Two-month follow-up via telephonic interviews to assess outcomes.
Main Results:
- Establishment of a biobank and database for severe pre-eclampsia in a high-incidence, low-middle income country setting.
- Integration of diverse data types including clinical, biological, and advanced imaging.
- Foundation laid for future research into pre-eclampsia pathophysiology and complications.
Conclusions:
- The biobank provides a crucial resource for studying severe pre-eclampsia in South Africa.
- This initiative will enhance understanding of disease mechanisms and aid in predicting organ damage.
- The data generated can inform future drug evaluation and discovery for pre-eclampsia.
Abstract:
Pre-eclampsia is a leading cause of maternal and perinatal morbidity and mortality. The burden of disease lies mainly in low-middle income countries. The aim of this project is to establish a pre-eclampsia biobank in South Africa to facilitate research in the field of pre-eclampsia with a focus on phenotyping severe disease.The approach of our biobank is to collect biological specimens, detailed clinical data, tests, and biophysical examinations, including magnetic resonance imaging (MRI) of the brain, MRI of the heart, transcranial Doppler, echocardiography, and cognitive function tests.Women diagnosed with pre-eclampsia and normotensive controls are enrolled in the biobank at admission to Tygerberg University Hospital (Cape Town, South Africa). Biological samples and clinical data are collected at inclusion/delivery and during the hospital stay. Special investigations as per above are performed in a subset of women. After two months, women are followed up by telephonic interviews. This project aims to establish a biobank and database for severe organ complications of pre-eclampsia in a low-middle income country where the incidence of pre-eclampsia with organ complications is high. The study integrates different methods to investigate pre-eclampsia, focusing on improved understanding of pathophysiology, prediction of organ complications, and potentially future drug evaluation and discovery.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024